Stocks Reaffirm To Gain Attentions: CVS Health Corporation (NYSE:CVS)

Stocks Reaffirm To Gain Attentions: CVS Health Corporation (NYSE:CVS)

The number of shares now owned by investors are 1.03 bln. MD now owns 14,400,092 shares of the pharmacy operator's stock valued at $1,281,464,000 after buying an additional 4,699,619 shares during the period. The stock stands almost -25.17% off versus the 52-week high and 14.12% away from the 52-week low. Price T Rowe Associates Inc. CVS Health Corp's revenue for the quarter was up 11.7% on a year-over-year basis. In the last quarter, insiders sold 176,947 shares of company stock worth $14,224,010. East Coast Asset Management LLC. increased its position in CVS Health Corp by 0.3% in the third quarter.

Stock is now moving with a negative distance from the 200 day simple moving average of approximately -8.3%, and has a solid year to date (YTD) performance of 0.22% which means the stock is constantly adding to its value from the previous fiscal year end price.

On 9/25/2013 CVS Health Corp announced a quarterly dividend of $0.23 1.55% with an ex dividend date of 10/17/2013 which will be payable on 11/1/2013.

The consensus recommendation, according to Zacks Investment research, is 1.83.

CVS Health Corporation (NYSE:CVS) [Trend Analysis] tries to capture market sentiments, shares eased down -0.85% to $78.88. CVS Health Corp has a 1-year low of $69.30 and a 1-year high of $106.67. The Average Volume of the company is 6.78 Million and P/E (price to earnings) ratio is 15.95, while Forward P/E ratio is 12.32. The stock is now trading -0.70% below its SMA 50 and 11.70% above its SMA 200.

CVS Health Corporation (NYSE:CVS) yearly performance is -20.45% and net profit margin is 3.00%. For the Q4 this year, the consensus current earnings per share trend estimates were for $1.10 while for one month ago was $1.11. According to these analysts, the Low Revenue Estimate for CVS Health Corporation is 43.93 Billion and the High Revenue Estimate is 45.4 Billion. The company's outstanding shares are 947.65 Million. The company is estimating to achieve earnings per share (EPS) growth of 5.60% in this year and the earnings per share (EPS) growth expected to be 8.87% in the next year.

The company also recently declared a quarterly dividend, which will be paid on Monday, May 1st. The number of shares now owned by investors are 50.16 mln. The co has dividend yield of 2.54% that is also considered as effective indicator.

CVS has been the subject of a number of analyst reports.

Shares of CVS Health Corporation (NYSE:CVS) dropped -0.85% to $78.88. Oppenheimer Holdings Inc. set a $88.00 target price on shares of CVS Health Corp and gave the stock a "buy" rating in a research note on Sunday, December 18th. Chilton Capital Management LLC's holdings in CVS Health Corp were worth $8,381,000 as of its most recent SEC filing. Price targets frequently change, depending on the outlook for a company's earnings. Bank of America Corp reissued a "buy" rating and issued a $106.67 price target on shares of CVS Health Corp in a research report on Tuesday, February 28th. The Mean and Low price Targets are $86.52 and $66.9, respectively. Eight equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. At recent closing price of $2.77, AUY has a chance to add $1.32 or 47.65% in 52 weeks, based on mean target price ($4.09) placed by analysts.The analyst consensus opinion of 2.8 looks like a hold. The stock was sold at an average price of $79.60, for a total value of $479,908.40.

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

In related news, EVP Jonathan C. Roberts sold 61,196 shares of the firm's stock in a transaction that occurred on Thursday, February 16th. Following the completion of the sale, the executive vice president now directly owns 89,955 shares in the company, valued at $7,196,400. The disclosure for this sale can be found here.

CVS Health Corporation (CVS) has the market capitalization of $80.91 Billion. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.



Other news